Dynamic transition of the blood-brain barrier in the development of non-small cell lung cancer
Effective drug delivery through the BTB is one of the greatest therapeutic obstacles in treating…
Browsing: non-small cell lung cancer
ESMO 2019: Blood test can replace invasive biopsy for more patients with lung cancer
A growing number of patients with advanced lung cancer could soon be offered a blood…
ASCO 2019: The eight biggest stories on anticancer agents
Here is ecancer’s speedy recap on the presentations from the 2019 American Society of Clinical…
ASCO 2019: Use of broader criteria for clinical trial enrolment would double number of eligible patients with lung cancer
A study looking at 10,500 health records of advanced non-small cell lung cancer (aNSCLC) patients…
ASCO 2019: Pembrolizumab increases historic survival rate for certain people with advanced non-small cell lung cancer
Five-year data from the phase Ib KEYNOTE-001 clinical trial show that pembrolizumab was safe and…
Biologists design new molecules to help stall lung cancer
University of Texas at Dallas scientists have demonstrated that the growth rate of the majority…
ELCC 2019: Studies give new insights on immunotherapy in elderly patients with advanced NSCLC
Two studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of…
Prophylactic cranial irradiation: Improvements for advanced NSCLC
Prophylactic cranial irradiation (PCI), a technique used to prevent the clinical development of brain metastases,…
CHMP announched positive opinion for brigatinib as treatment of ALK positive NSCLC in patients previously treated with crizotinib
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive…
Study shows invasive lung cancer surgery can lead to long-term opioid use
Patients treated with more-invasive surgical techniques for a type of early-stage lung cancer are more…